<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 9.4: Environmental Immunotoxicity: Toxins as Immune Disruptors</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE theme for Immunology */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs & Highlights */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #dae7ff 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #1e3a8a;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #1e40af 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #3b82f6;
            color: white;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 16px;
            text-align: left;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #e2e8f0;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffcf0;
            border: 2px solid #d4a84b;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
            border-left: 4px solid #22c55e;
        }

        /* Key Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fafafa;
            border-radius: 12px;
            font-size: 14px;
            color: #666;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin-top: 0;
            color: #1e3a8a;
        }

        .lesson-footer {
            text-align: center;
            margin-top: 60px;
            padding-top: 30px;
            border-top: 1px solid #eee;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 9: Immunometabolism & Chronic Inflammation</p>
            <h1 class="lesson-title">Lesson 9.4: Environmental Immunotoxicity: Toxins as Immune Disruptors</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#mechanisms"><span class="section-num">1</span>Mechanisms of Immunotoxicity</a></li>
                <li><a href="#mycotoxins"><span class="section-num">2</span>Mycotoxins: Silent Suppressors</a></li>
                <li><a href="#edcs"><span class="section-num">3</span>EDCs & Th1/Th2 Imbalance</a></li>
                <li><a href="#total-load"><span class="section-num">4</span>The Total Toxic Load Concept</a></li>
                <li><a href="#detox"><span class="section-num">5</span>Phase I-III Detoxification</a></li>
                <li><a href="#testing"><span class="section-num">6</span>Functional Lab Assessment</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the molecular pathways by which heavy metals and POPs disrupt cytokine signaling and immune surveillance.</li>
                <li>Evaluate the suppressive mechanisms of Ochratoxin and Aflatoxin on adaptive immunity (T and B cell function).</li>
                <li>Explain how Endocrine Disrupting Chemicals (EDCs) act as root-cause drivers for skewed Th1/Th2 ratios.</li>
                <li>Synthesize a clinical strategy for supporting Phase I-III hepatic clearance to reduce systemic immunotoxicity.</li>
                <li>Interpret functional lab markers, including Organic Acid Testing (OAT) and toxic non-metal chemical profiles.</li>
            </ul>
        </div>

        <h2 id="mechanisms">1. Mechanisms of Immunotoxicity: Signaling Disruption</h2>
        <p>In the <span class="highlight">B.R.I.D.G.E. Methodâ„¢</span>, we define environmental toxins not merely as "poisons," but as <span class="highlight">metabolic and immune signals</span>. Immunotoxicity refers to the adverse effects of xenobiotics on the immune system, which can manifest as either immunosuppression (leading to infection or cancer) or immunostimulation (leading to autoimmunity or hypersensitivity).</p>

        <p>Heavy metals like Mercury (Hg) and Lead (Pb) are potent disruptors of the <span class="highlight">NF-ÎºB pathway</span>, the master regulator of inflammation. Mercury, in particular, has a high affinity for sulfhydryl groups on proteins, leading to structural alterations in cell surface receptors and intracellular signaling molecules. This "molecular mimicry" or structural distortion can trigger the production of autoantibodies.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">42%</div>
                    <div class="stat-label">Increase in Autoantibody Prevalence</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">12k+</div>
                    <div class="stat-label">Participants in NHANES Toxin Study</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3.5x</div>
                    <div class="stat-label">Risk Multiplier for High Lead Levels</div>
                </div>
            </div>
        </div>

        <p>Persistent Organic Pollutants (POPs), such as dioxins and polychlorinated biphenyls (PCBs), act primarily through the <span class="highlight">Aryl Hydrocarbon Receptor (AhR)</span>. The AhR is a ligand-activated transcription factor expressed in many immune cells, including T-cells and dendritic cells. When POPs bind to AhR, they can force the differentiation of T-cells into Th17 cells (pro-inflammatory) while suppressing Treg cells (regulatory), effectively dismantling the body's self-tolerance mechanisms.</p>

        <h2 id="mycotoxins">2. Mycotoxins: The Silent Immune Suppressors</h2>
        <p>Mycotoxinsâ€”secondary metabolites produced by microfungiâ€”are among the most prevalent yet overlooked immunotoxins in modern practice. Unlike heavy metals, which often provoke an inflammatory response, many mycotoxins are primarily <span class="highlight">lymphocytotoxic</span>, meaning they directly kill or inhibit the proliferation of white blood cells.</p>

        <div class="principle-card">
            <div class="principle-title">Ochratoxin A (OTA) & T-Cell Arrest</div>
            <div class="principle-text">
                Ochratoxin A, commonly found in water-damaged buildings and contaminated grains, inhibits protein synthesis by competing with the amino acid phenylalanine. In the immune system, this leads to:
                <ul>
                    <li>Reduced Interleukin-2 (IL-2) production, stalling T-cell clonal expansion.</li>
                    <li>Induction of apoptosis in thymocytes, leading to thymic atrophy.</li>
                    <li>Decreased phagocytic activity of macrophages.</li>
                </ul>
            </div>
        </div>

        <p>Aflatoxins (specifically B1) are potent inhibitors of B-cell function. Research indicates that chronic Aflatoxin exposure reduces the production of <span class="highlight">Secretory IgA (sIgA)</span> in the gut mucosa, directly compromising the "First Line of Defense" we discussed in Lesson 9.3. This creates a vicious cycle where the gut barrier becomes more permeable to further toxins, increasing the "Total Toxic Load."</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The Mold-Immune Connection</p>
                    <p style="color: rgba(255,255,255,0.8); margin: 0; font-size: 13px;">Chronic Fatigue and Recurrent Sinusitis</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">J</div>
                    <div class="patient-info">
                        <h4>James, 38, Software Engineer</h4>
                        <p>Symptoms: Brain fog, chronic sinusitis, sensitivity to smells, and unexplained joint pain.</p>
                    </div>
                </div>
                <p><strong>Assessment:</strong> James worked in a basement office with a history of water leaks. Conventional labs were unremarkable except for slightly low WBC (3.8 x 10Â³/ÂµL). Functional testing revealed elevated <strong>Ochratoxin A</strong> (34.2 ng/g) and <strong>Mycophenolic Acid</strong>.</p>
                <p><strong>Intervention:</strong> james was moved to a remediated environment and started on a protocol of liposomal glutathione, sequestering binders (activated charcoal and clay), and Phase II conjugation support (NAC, Sulforaphane).</p>
                <p><strong>Outcome:</strong> Within 4 months, his sIgA levels normalized, joint pain resolved, and his "brain fog" lifted as his systemic inflammatory markers (hs-CRP) dropped from 4.2 to 0.8 mg/L.</p>
            </div>
        </div>

        <h2 id="edcs">3. Endocrine Disrupting Chemicals (EDCs) & Th1/Th2 Imbalance</h2>
        <p>Endocrine Disrupting Chemicals (EDCs), such as Bisphenol A (BPA), Phthalates, and Parabens, are notorious for their ability to mimic estrogen. However, their role as <span class="highlight">immunomodulators</span> is equally significant. Estrogen receptors (ERÎ± and ERÎ²) are present on almost all immune cells, and EDCs can "hijack" these receptors to alter immune signaling.</p>

        <p>A 2022 meta-analysis demonstrated that BPA exposure is strongly correlated with a <span class="highlight">Th2-dominant immune shift</span>. This shift is characterized by an overproduction of IL-4, IL-5, and IL-13, which promotes IgE production and allergic sensitization. This provides a molecular explanation for the rising rates of asthma and atopic dermatitis in industrialized nations.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Toxin Category</th>
                        <th>Primary Immune Effect</th>
                        <th>Cytokine Shift</th>
                        <th>Clinical Manifestation</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Heavy Metals (Hg, Pb)</strong></td>
                        <td>NF-ÎºB Activation / Mimicry</td>
                        <td>â†‘ TNF-Î±, â†‘ IL-6</td>
                        <td>Autoimmunity, Chronic Pain</td>
                    </tr>
                    <tr>
                        <td><strong>Mycotoxins (OTA)</strong></td>
                        <td>Protein Synthesis Inhibition</td>
                        <td>â†“ IL-2, â†“ sIgA</td>
                        <td>Immunosuppression, Infections</td>
                    </tr>
                    <tr>
                        <td><strong>EDCs (BPA, Phthalates)</strong></td>
                        <td>Estrogen Receptor Hijacking</td>
                        <td>â†‘ IL-4 (Th2 Shift)</td>
                        <td>Allergies, Asthma, Mast Cell Activation</td>
                    </tr>
                    <tr>
                        <td><strong>POPs (PCBs, Dioxins)</strong></td>
                        <td>AhR Binding</td>
                        <td>â†‘ Th17 / â†“ Treg</td>
                        <td>Loss of Tolerance, IBD</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="total-load">4. The Total Toxic Load & The B.R.I.D.G.E. Methodâ„¢</h2>
        <p>In the <span class="highlight">Root Cause Analysis</span> phase of the B.R.I.D.G.E. Methodâ„¢, we must move beyond the "one toxin, one disease" model. We utilize the concept of <span class="highlight">Total Toxic Load</span> (or Toxic Burden), which is the cumulative effect of all environmental stressors on the individual's physiological capacity to maintain homeostasis.</p>

        <p>An individual might tolerate a low level of Mercury exposure if their glutathione status is optimal and their gut barrier is intact. However, if that same individual is exposed to Ochratoxin (which depletes glutathione) and Glyphosate (which disrupts the gut microbiome), the Mercury that was once "manageable" becomes immunotoxic. This is the <span class="highlight">Synergistic Toxicity</span> model.</p>

        <h2 id="detox">5. Phase I-III Detoxification: Supporting Hepatic Clearance</h2>
        <p>To reduce immunotoxicity, we must optimize the three phases of detoxification. Practitioners often focus on Phase I and II, but <span class="highlight">Phase III (Excretion)</span> is frequently the clinical bottleneck.</p>

        <div class="principle-card">
            <div class="principle-title">Phase I: Functionalization</div>
            <p class="principle-text">The Cytochrome P450 enzymes "activate" toxins by adding a reactive group (like -OH). This often makes the toxin <em>more</em> reactive and potentially more immunotoxic (reactive oxygen species production).</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Phase II: Conjugation</div>
            <p class="principle-text">The liver attaches a molecule (Glutathione, Sulfate, Methyl group, or Amino acid) to the activated toxin to make it water-soluble. <strong>Glutathione S-transferase (GST)</strong> is the most critical enzyme for neutralizing heavy metals and POPs.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Phase III: Transport & Excretion</div>
            <p class="principle-text">Antiporter proteins (like P-glycoprotein) pump the conjugated toxins into the bile or urine. If the patient is constipated or has low bile flow (cholestasis), toxins are de-conjugated by gut bacteria (via beta-glucuronidase) and re-absorbed into the bloodstreamâ€”a process called <strong>enterohepatic recirculation</strong>.</p>
        </div>

        <h2 id="testing">6. Functional Lab Assessment: Data-Driven Decisions</h2>
        <p>As an Integrative Medicine Practitioner, you must use <span class="highlight">Data-Driven Decisions</span> to identify these hidden triggers. Traditional blood tests for toxins (like a blood lead level) only show <em>recent</em> exposure. To assess the <em>Total Toxic Load</em>, we look at markers of metabolic breakdown and stored burden.</p>

        <ul>
            <li><strong>Organic Acid Testing (OAT):</strong> Look for markers like <em>Pyroglutamic acid</em> (indicates glutathione depletion) and <em>2-Hydroxybutyric acid</em> (indicates high oxidative stress and glutathione turnover).</li>
            <li><strong>Toxic Non-Metal Chemical Profile (GPL-TOX):</strong> Measures metabolites of EDCs, organophosphates, and volatile organic compounds (VOCs) in the urine.</li>
            <li><strong>Mycotoxin Panels:</strong> Uses LC-MS/MS technology to detect specific fungal metabolites in the urine.</li>
            <li><strong>Gamma-Glutamyl Transferase (GGT):</strong> While often used for liver health, a GGT in the "high-normal" range (e.g., >25 U/L) is a sensitive marker for environmental toxin exposure and the need for glutathione mobilization.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why might a patient's symptoms worsen during the initial stages of a "detox" protocol if Phase III is not supported?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">If Phase III (excretion) is sluggish (e.g., constipation or poor bile flow), toxins that have been "activated" in Phase I and conjugated in Phase II may be de-conjugated by gut bacteria and re-absorbed. These intermediate metabolites are often more reactive and immunotoxic than the original toxin, leading to a "flare" in systemic inflammation.</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Which cytokine shift is most commonly associated with chronic exposure to Endocrine Disrupting Chemicals (EDCs) like BPA?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">EDCs typically promote a Th2-dominant shift (increased IL-4, IL-5), which can lead to increased allergic responses, mast cell activation, and a higher risk of atopic conditions.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Toxins are Signaling Molecules:</strong> They don't just cause damage; they reprogram the immune system via receptors like AhR and ERÎ±.</li>
                <li><strong>The AhR Pathway:</strong> POPs use this receptor to skew the immune system toward Th17 (pro-inflammatory) and away from Treg (regulatory).</li>
                <li><strong>Mycotoxins are Lymphocytotoxic:</strong> They directly impair T and B cell function, often presenting as chronic low-grade immunosuppression.</li>
                <li><strong>Detoxification is a Three-Part Process:</strong> Clinical success requires supporting Phase II conjugation (Glutathione) and Phase III excretion (Bile/Bowel) simultaneously.</li>
                <li><strong>Data Over Guesswork:</strong> Use OAT and Mycotoxin panels to identify specific triggers rather than applying generic "cleanses."</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul style="list-style: none; padding: 0;">
                <li>Kolluru et al. (2023). "Environmental Toxins and the Immune System: A Review of Mechanisms." <em>Journal of Immunotoxicology.</em></li>
                <li>Dietert, R. R. (2021). "The Microbiome-Immune-Toxicity Axis." <em>International Journal of Molecular Sciences.</em></li>
                <li>Hope, J. (2013). "A Review of the Mechanism of Injury and Treatment Approaches for Illness Resulting from Exposure to Water-Damaged Buildings, Mold, and Mycotoxins." <em>Scientific World Journal.</em></li>
                <li>Nowak et al. (2019). "Bisphenol A and its effects on the immune system." <em>Postepy Higieny i Medycyny Doswiadczalnej.</em></li>
                <li>Sears, M. E., & Genuis, S. J. (2012). "Environmental Determinants of Chronic Disease and Medical Approaches: Recognition, Avoidance, Supportive Therapy, and Detoxification." <em>Journal of Environmental and Public Health.</em></li>
                <li>Vojdani, A. (2014). "A Potential Link between Environmental Triggers and Autoimmunity." <em>Autoimmune Diseases.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. The B.R.I.D.G.E. Methodâ„¢ is a proprietary framework.</p>
        </footer>
    </div>
</body>

</html>